HEADER CYTOKINE 11-AUG-20 7JRA TITLE HUMAN TNF-ALPHA IN COMPLEX WITH 2-[5-(3-CHLORO-4-{[(1R)-1-(2- TITLE 2 FLUOROPHENYL)ETHYL]AMINO}QUINOLIN-6-YL)PYRIMIDIN-2-YL]PROPAN-2-OL COMPND MOL_ID: 1; COMPND 2 MOLECULE: TUMOR NECROSIS FACTOR; COMPND 3 CHAIN: A, B, C; COMPND 4 SYNONYM: CACHECTIN,TNF-ALPHA,TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY COMPND 5 MEMBER 2,TNF-A; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: TNF, TNFA, TNFSF2; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PET28 KEYWDS TUMOR NECROSIS FACTOR ALPHA, TNF, ASYMMETRIC, PROTEIN-PROTEIN KEYWDS 2 INTERACTION INHIBITOR, INHIBITOR, CYTOKINE, LYMPHOKINE EXPDTA X-RAY DIFFRACTION AUTHOR S.SHERIFF REVDAT 4 18-OCT-23 7JRA 1 REMARK REVDAT 3 13-JAN-21 7JRA 1 JRNL REVDAT 2 23-DEC-20 7JRA 1 JRNL REVDAT 1 09-DEC-20 7JRA 0 JRNL AUTH H.Y.XIAO,N.LI,J.J.DUAN,B.JIANG,Z.LU,K.NGU,J.TINO,L.M.KOPCHO, JRNL AUTH 2 H.LU,J.CHEN,A.J.TEBBEN,S.SHERIFF,C.Y.CHANG,J.YANCHUNAS JR., JRNL AUTH 3 D.CALAMBUR,M.GAO,D.J.SHUSTER,V.SUSULIC,J.H.XIE,V.R.GUARINO, JRNL AUTH 4 D.R.WU,K.R.GREGOR,C.B.GOLDSTINE,J.HYNES JR.,J.E.MACOR, JRNL AUTH 5 L.SALTER-CID,J.R.BURKE,P.J.SHAW,T.G.M.DHAR JRNL TITL BIOLOGIC-LIKE IN VIVO EFFICACY WITH SMALL MOLECULE JRNL TITL 2 INHIBITORS OF TNF ALPHA IDENTIFIED USING SCAFFOLD HOPPING JRNL TITL 3 AND STRUCTURE-BASED DRUG DESIGN APPROACHES. JRNL REF J.MED.CHEM. V. 63 15050 2020 JRNL REFN ISSN 0022-2623 JRNL PMID 33261314 JRNL DOI 10.1021/ACS.JMEDCHEM.0C01732 REMARK 2 REMARK 2 RESOLUTION. 2.10 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.6 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.10 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 24.21 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.3 REMARK 3 NUMBER OF REFLECTIONS : 24694 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.196 REMARK 3 R VALUE (WORKING SET) : 0.195 REMARK 3 FREE R VALUE : 0.235 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 2.010 REMARK 3 FREE R VALUE TEST SET COUNT : 496 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 12 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.10 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.19 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 95.29 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2840 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2055 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2787 REMARK 3 BIN R VALUE (WORKING SET) : 0.2055 REMARK 3 BIN FREE R VALUE : 0.2085 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 1.87 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 53 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3302 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 37 REMARK 3 SOLVENT ATOMS : 170 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 25.00 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 29.03 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -3.01610 REMARK 3 B22 (A**2) : 1.99630 REMARK 3 B33 (A**2) : 1.01980 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.295 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.244 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.187 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.237 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.186 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.935 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.914 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 3451 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 4737 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 1096 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 72 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 543 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 3451 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 449 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 3963 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.17 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 3.90 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 16.18 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 7JRA COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 12-AUG-20. REMARK 100 THE DEPOSITION ID IS D_1000251274. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 10-SEP-15 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU FR-E SUPERBRIGHT REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.54 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : VARIMAX HF ARC)SEC CONFOCAL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 200K REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 24773 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.100 REMARK 200 RESOLUTION RANGE LOW (A) : 92.970 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.4 REMARK 200 DATA REDUNDANCY : 6.300 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.11200 REMARK 200 FOR THE DATA SET : 12.8000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.10 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.21 REMARK 200 COMPLETENESS FOR SHELL (%) : 96.3 REMARK 200 DATA REDUNDANCY IN SHELL : 5.70 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.50400 REMARK 200 FOR SHELL : 3.700 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: 2AZ5 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 36.89 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.95 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 100 MM HEPES, PH 7.5, 13% (W/V) REMARK 280 MEPEG5000, 3% (V/V) DIOXANE, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 27.24000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 46.48500 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 40.85500 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 46.48500 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 27.24000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 40.85500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 5560 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 18660 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -34.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 74 REMARK 465 HIS A 75 REMARK 465 MET A 76 REMARK 465 VAL A 77 REMARK 465 ARG A 78 REMARK 465 SER A 79 REMARK 465 SER A 80 REMARK 465 GLY B 74 REMARK 465 HIS B 75 REMARK 465 MET B 76 REMARK 465 VAL B 77 REMARK 465 ARG B 78 REMARK 465 SER B 79 REMARK 465 SER B 80 REMARK 465 SER B 81 REMARK 465 PRO B 182 REMARK 465 GLU B 183 REMARK 465 GLY B 184 REMARK 465 ALA B 185 REMARK 465 GLU B 186 REMARK 465 ALA B 187 REMARK 465 GLY C 74 REMARK 465 HIS C 75 REMARK 465 MET C 76 REMARK 465 VAL C 77 REMARK 465 ARG C 78 REMARK 465 SER C 79 REMARK 465 SER C 80 REMARK 465 SER C 81 REMARK 465 ARG C 82 REMARK 465 THR C 83 REMARK 465 PRO C 84 REMARK 465 THR C 181 REMARK 465 PRO C 182 REMARK 465 GLU C 183 REMARK 465 GLY C 184 REMARK 465 ALA C 185 REMARK 465 GLU C 186 REMARK 465 ALA C 187 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 SER A 81 OG REMARK 470 ARG A 82 CG CD NE CZ NH1 NH2 REMARK 470 THR A 83 OG1 CG2 REMARK 470 GLU A 129 CD OE1 OE2 REMARK 470 GLN A 143 CD OE1 NE2 REMARK 470 SER A 147 OG REMARK 470 GLN A 178 CG CD OE1 NE2 REMARK 470 ARG A 179 CG CD NE CZ NH1 NH2 REMARK 470 GLU A 180 CG CD OE1 OE2 REMARK 470 GLU A 186 CG CD OE1 OE2 REMARK 470 LYS A 188 CG CD CE NZ REMARK 470 GLU A 222 CG CD OE1 OE2 REMARK 470 ARG B 82 CG CD NE CZ NH1 NH2 REMARK 470 THR B 83 OG1 CG2 REMARK 470 ASP B 86 CG OD1 OD2 REMARK 470 GLU B 99 CG CD OE1 OE2 REMARK 470 GLN B 164 CG CD OE1 NE2 REMARK 470 GLN B 178 CG CD OE1 NE2 REMARK 470 ARG B 179 CG CD NE CZ NH1 NH2 REMARK 470 GLU B 180 CG CD OE1 OE2 REMARK 470 LYS B 188 CG CD CE NZ REMARK 470 GLU B 222 CG CD OE1 OE2 REMARK 470 SER C 85 OG REMARK 470 ASP C 86 CG OD1 OD2 REMARK 470 LYS C 87 CE NZ REMARK 470 GLN C 97 CG CD OE1 NE2 REMARK 470 GLU C 99 CG CD OE1 OE2 REMARK 470 GLN C 101 CG CD OE1 NE2 REMARK 470 ASN C 106 CG OD1 ND2 REMARK 470 ARG C 107 CG CD NE CZ NH1 NH2 REMARK 470 ARG C 108 CZ NH1 NH2 REMARK 470 GLU C 118 CD OE1 OE2 REMARK 470 ARG C 120 CD NE CZ NH1 NH2 REMARK 470 GLU C 129 CD OE1 OE2 REMARK 470 GLN C 143 CD OE1 NE2 REMARK 470 SER C 147 OG REMARK 470 THR C 148 OG1 CG2 REMARK 470 SER C 162 OG REMARK 470 TYR C 163 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 GLN C 164 CG CD OE1 NE2 REMARK 470 GLN C 178 CG CD OE1 NE2 REMARK 470 ARG C 179 CG CD NE CZ NH1 NH2 REMARK 470 GLU C 180 CG CD OE1 OE2 REMARK 470 LYS C 188 CG CD CE NZ REMARK 470 GLU C 222 CG CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 147 179.98 175.98 REMARK 500 TYR A 163 78.68 -156.09 REMARK 500 GLU A 180 144.63 68.95 REMARK 500 ALA A 221 -70.11 -58.92 REMARK 500 GLU B 180 147.77 71.65 REMARK 500 ALA C 109 -83.89 -16.23 REMARK 500 ASN C 110 41.00 -109.51 REMARK 500 SER C 162 -64.09 76.61 REMARK 500 THR C 165 109.88 -47.00 REMARK 500 ARG C 214 73.86 -119.52 REMARK 500 ALA C 221 121.40 -39.20 REMARK 500 GLU C 222 48.95 -67.52 REMARK 500 REMARK 500 REMARK: NULL DBREF 7JRA A 77 233 UNP P01375 TNFA_HUMAN 77 233 DBREF 7JRA B 77 233 UNP P01375 TNFA_HUMAN 77 233 DBREF 7JRA C 77 233 UNP P01375 TNFA_HUMAN 77 233 SEQADV 7JRA GLY A 74 UNP P01375 EXPRESSION TAG SEQADV 7JRA HIS A 75 UNP P01375 EXPRESSION TAG SEQADV 7JRA MET A 76 UNP P01375 EXPRESSION TAG SEQADV 7JRA GLY B 74 UNP P01375 EXPRESSION TAG SEQADV 7JRA HIS B 75 UNP P01375 EXPRESSION TAG SEQADV 7JRA MET B 76 UNP P01375 EXPRESSION TAG SEQADV 7JRA GLY C 74 UNP P01375 EXPRESSION TAG SEQADV 7JRA HIS C 75 UNP P01375 EXPRESSION TAG SEQADV 7JRA MET C 76 UNP P01375 EXPRESSION TAG SEQRES 1 A 160 GLY HIS MET VAL ARG SER SER SER ARG THR PRO SER ASP SEQRES 2 A 160 LYS PRO VAL ALA HIS VAL VAL ALA ASN PRO GLN ALA GLU SEQRES 3 A 160 GLY GLN LEU GLN TRP LEU ASN ARG ARG ALA ASN ALA LEU SEQRES 4 A 160 LEU ALA ASN GLY VAL GLU LEU ARG ASP ASN GLN LEU VAL SEQRES 5 A 160 VAL PRO SER GLU GLY LEU TYR LEU ILE TYR SER GLN VAL SEQRES 6 A 160 LEU PHE LYS GLY GLN GLY CYS PRO SER THR HIS VAL LEU SEQRES 7 A 160 LEU THR HIS THR ILE SER ARG ILE ALA VAL SER TYR GLN SEQRES 8 A 160 THR LYS VAL ASN LEU LEU SER ALA ILE LYS SER PRO CYS SEQRES 9 A 160 GLN ARG GLU THR PRO GLU GLY ALA GLU ALA LYS PRO TRP SEQRES 10 A 160 TYR GLU PRO ILE TYR LEU GLY GLY VAL PHE GLN LEU GLU SEQRES 11 A 160 LYS GLY ASP ARG LEU SER ALA GLU ILE ASN ARG PRO ASP SEQRES 12 A 160 TYR LEU ASP PHE ALA GLU SER GLY GLN VAL TYR PHE GLY SEQRES 13 A 160 ILE ILE ALA LEU SEQRES 1 B 160 GLY HIS MET VAL ARG SER SER SER ARG THR PRO SER ASP SEQRES 2 B 160 LYS PRO VAL ALA HIS VAL VAL ALA ASN PRO GLN ALA GLU SEQRES 3 B 160 GLY GLN LEU GLN TRP LEU ASN ARG ARG ALA ASN ALA LEU SEQRES 4 B 160 LEU ALA ASN GLY VAL GLU LEU ARG ASP ASN GLN LEU VAL SEQRES 5 B 160 VAL PRO SER GLU GLY LEU TYR LEU ILE TYR SER GLN VAL SEQRES 6 B 160 LEU PHE LYS GLY GLN GLY CYS PRO SER THR HIS VAL LEU SEQRES 7 B 160 LEU THR HIS THR ILE SER ARG ILE ALA VAL SER TYR GLN SEQRES 8 B 160 THR LYS VAL ASN LEU LEU SER ALA ILE LYS SER PRO CYS SEQRES 9 B 160 GLN ARG GLU THR PRO GLU GLY ALA GLU ALA LYS PRO TRP SEQRES 10 B 160 TYR GLU PRO ILE TYR LEU GLY GLY VAL PHE GLN LEU GLU SEQRES 11 B 160 LYS GLY ASP ARG LEU SER ALA GLU ILE ASN ARG PRO ASP SEQRES 12 B 160 TYR LEU ASP PHE ALA GLU SER GLY GLN VAL TYR PHE GLY SEQRES 13 B 160 ILE ILE ALA LEU SEQRES 1 C 160 GLY HIS MET VAL ARG SER SER SER ARG THR PRO SER ASP SEQRES 2 C 160 LYS PRO VAL ALA HIS VAL VAL ALA ASN PRO GLN ALA GLU SEQRES 3 C 160 GLY GLN LEU GLN TRP LEU ASN ARG ARG ALA ASN ALA LEU SEQRES 4 C 160 LEU ALA ASN GLY VAL GLU LEU ARG ASP ASN GLN LEU VAL SEQRES 5 C 160 VAL PRO SER GLU GLY LEU TYR LEU ILE TYR SER GLN VAL SEQRES 6 C 160 LEU PHE LYS GLY GLN GLY CYS PRO SER THR HIS VAL LEU SEQRES 7 C 160 LEU THR HIS THR ILE SER ARG ILE ALA VAL SER TYR GLN SEQRES 8 C 160 THR LYS VAL ASN LEU LEU SER ALA ILE LYS SER PRO CYS SEQRES 9 C 160 GLN ARG GLU THR PRO GLU GLY ALA GLU ALA LYS PRO TRP SEQRES 10 C 160 TYR GLU PRO ILE TYR LEU GLY GLY VAL PHE GLN LEU GLU SEQRES 11 C 160 LYS GLY ASP ARG LEU SER ALA GLU ILE ASN ARG PRO ASP SEQRES 12 C 160 TYR LEU ASP PHE ALA GLU SER GLY GLN VAL TYR PHE GLY SEQRES 13 C 160 ILE ILE ALA LEU HET VGY B 301 53 HET GOL B 302 6 HETNAM VGY 2-[5-(3-CHLORO-4-{[(1R)-1-(2-FLUOROPHENYL) HETNAM 2 VGY ETHYL]AMINO}QUINOLIN-6-YL)PYRIMIDIN-2-YL]PROPAN-2-OL HETNAM GOL GLYCEROL HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 4 VGY C24 H22 CL F N4 O FORMUL 5 GOL C3 H8 O3 FORMUL 6 HOH *170(H2 O) HELIX 1 AA1 ARG A 214 LEU A 218 5 5 HELIX 2 AA2 ARG B 214 LEU B 218 5 5 HELIX 3 AA3 ARG C 214 LEU C 218 5 5 SHEET 1 AA1 3 TRP A 104 LEU A 105 0 SHEET 2 AA1 3 VAL A 89 ALA A 94 -1 N VAL A 93 O LEU A 105 SHEET 3 AA1 3 LEU A 112 ALA A 114 -1 O ALA A 114 N VAL A 89 SHEET 1 AA2 5 TRP A 104 LEU A 105 0 SHEET 2 AA2 5 VAL A 89 ALA A 94 -1 N VAL A 93 O LEU A 105 SHEET 3 AA2 5 TYR A 227 ALA A 232 -1 O PHE A 228 N VAL A 92 SHEET 4 AA2 5 GLY A 130 GLN A 143 -1 N TYR A 135 O GLY A 229 SHEET 5 AA2 5 PRO A 189 LEU A 202 -1 O LEU A 202 N GLY A 130 SHEET 1 AA3 5 GLU A 118 ARG A 120 0 SHEET 2 AA3 5 GLN A 123 VAL A 125 -1 O VAL A 125 N GLU A 118 SHEET 3 AA3 5 ARG A 207 ILE A 212 -1 O LEU A 208 N LEU A 124 SHEET 4 AA3 5 LEU A 152 ALA A 160 -1 N THR A 155 O GLU A 211 SHEET 5 AA3 5 TYR A 163 LYS A 174 -1 O LEU A 169 N ILE A 156 SHEET 1 AA4 3 TRP B 104 LEU B 105 0 SHEET 2 AA4 3 VAL B 89 ALA B 94 -1 N VAL B 93 O LEU B 105 SHEET 3 AA4 3 LEU B 112 ALA B 114 -1 O LEU B 112 N HIS B 91 SHEET 1 AA5 5 TRP B 104 LEU B 105 0 SHEET 2 AA5 5 VAL B 89 ALA B 94 -1 N VAL B 93 O LEU B 105 SHEET 3 AA5 5 TYR B 227 ALA B 232 -1 O PHE B 228 N VAL B 92 SHEET 4 AA5 5 GLY B 130 GLN B 143 -1 N TYR B 135 O GLY B 229 SHEET 5 AA5 5 PRO B 189 LEU B 202 -1 O LEU B 196 N SER B 136 SHEET 1 AA6 5 GLU B 118 ARG B 120 0 SHEET 2 AA6 5 GLN B 123 VAL B 125 -1 O VAL B 125 N GLU B 118 SHEET 3 AA6 5 ARG B 207 ILE B 212 -1 O LEU B 208 N LEU B 124 SHEET 4 AA6 5 LEU B 152 ALA B 160 -1 N THR B 155 O GLU B 211 SHEET 5 AA6 5 THR B 165 LYS B 174 -1 O LEU B 169 N ILE B 156 SHEET 1 AA7 3 TRP C 104 LEU C 105 0 SHEET 2 AA7 3 VAL C 89 ALA C 94 -1 N VAL C 93 O LEU C 105 SHEET 3 AA7 3 LEU C 112 ALA C 114 -1 O LEU C 112 N HIS C 91 SHEET 1 AA8 5 TRP C 104 LEU C 105 0 SHEET 2 AA8 5 VAL C 89 ALA C 94 -1 N VAL C 93 O LEU C 105 SHEET 3 AA8 5 TYR C 227 ALA C 232 -1 O PHE C 228 N VAL C 92 SHEET 4 AA8 5 GLY C 130 GLN C 143 -1 N TYR C 135 O GLY C 229 SHEET 5 AA8 5 PRO C 189 LEU C 202 -1 O LEU C 202 N GLY C 130 SHEET 1 AA9 5 GLU C 118 ARG C 120 0 SHEET 2 AA9 5 GLN C 123 VAL C 125 -1 O VAL C 125 N GLU C 118 SHEET 3 AA9 5 ARG C 207 ILE C 212 -1 O LEU C 208 N LEU C 124 SHEET 4 AA9 5 LEU C 152 ILE C 159 -1 N ILE C 159 O ARG C 207 SHEET 5 AA9 5 LYS C 166 LYS C 174 -1 O LEU C 169 N ILE C 156 SSBOND 1 CYS A 145 CYS A 177 1555 1555 2.05 SSBOND 2 CYS B 145 CYS B 177 1555 1555 2.03 SSBOND 3 CYS C 145 CYS C 177 1555 1555 2.03 CRYST1 54.480 81.710 92.970 90.00 90.00 90.00 P 21 21 21 12 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.018355 0.000000 0.000000 0.00000 SCALE2 0.000000 0.012238 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010756 0.00000